Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals

Cancer Surveys

Volumn 27, Issue , 1996, Pages 41-64

  Massagué, Joan ^a   Weis Garcia, Frances ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RECEPTOR SUBUNIT; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CARCINOGENESIS; CELL CYCLE; CELL GROWTH; GROWTH REGULATION; LIGAND BINDING; MITOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029904671     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (130)

1. Alexandrow MG and Moses HL (1995) Transforming growth factor β and cell cycle regulation. Cancer Research 55 1452-1457
2. Andres JL, Stanley K, Cheifetz S and Massagué J (1989) Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β. Journal of Biological Chemistry 109 3137-3145
3. Arora K, Dai H, Kazuko SG et al (1995) The Drosophila schnurri gene acts in the Dpp/TGFβ signaling pathway and encodes a transcription factor homologous to the human MBP family. Cell 81 781-790
4. Attisano L, Wrana JL, Cheifetz S and Massagué J (1992) Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68 97-108
5. Attisano L, Cárcamo J, Ventura F et al (1993) Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75 671-680
6. Attisano L, Wrana JL, Montalvo E and Massagué J (1996) Activation of signalling by the activin receptor complex. Molecular and Cellular Biology 16 1066-1073
7. Baarens WM, van Helmaond MJL, Post M et al (1994) A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 120 189-197
8. Bassing CH, Yingling JM, Howe DJ et al (1994) A transforming growth factor β type I receptor that signals to activate gene expression. Science 263 87-89
9. Border WA and Ruoslahti E (1992) Transforming growth factor-β in disease: the dark side of tissue repair. Journal of Clinical Investigation 90 1-7
10. Boyd FT and Massagué J (1989) Growth inhibitory response to transforming growth factor-β linked to expression of a 53 kDa cell surface TGF-β receptor. Journal of Biological Chemistry 264 2272-2278
11. Brand T and Schneider MD (1995) Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF-beta-dependent transcription. Journal of Biological Chemistry 270 8274-8284
12. Brand T, MacLelland WR and Schneider MD (1993) A dominant-negative receptor for type βtransforming growth factor created by deletion of the kinase domain. Journal of Biological Chemistry 268 11500-11503
13. Brummel T, Twombly V, Marques G et al (1994) Characterization and relationship of dpp receptors encoded by the saxophone and thick veins genes in Drosophila. Cell 78 251-261
14. Cárcamo J, Weis FMB, Ventura F et al (1994) Type I receptors specify growth inhibitory and transcriptional responses to TGF-β and activin. Molecular and Cellular Biology 14 3810-3821
15. Cárcamo J, Zentella A and Massagué J (1995) Disruption of TGF-β signaling by a mutation that prevents transphosphorylation within the receptor complex. Molecular and Cellular Biology 15 1573-1581
16. Cate RL, Mattaliano RJ, Hession C et al (1986) Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45 685-698
17. Cheifetz S, Weatherbee JA, Tsang ML-S et al (1987) The transforming growth factor-β system, a complex pattern of crossreactive ligands and receptors. Cell 48 409-415
18. Cheifetz S, Bellón T, Calés C et al (1992) Endoglin is a component of the TGF-β receptor system in human endothelial cells. Journal of Biological Chemistry 267 19027-19030
19. Chen F and Weinberg RA (1995) Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proceedings of the National Academy of Sciences of the USA 92 1565-1569
20. Chen R-H and Derynck R (1994) Homomeric interactions between type II transforming growth factor-β receptors. Journal of Biological Chemistry 269 22868-22874
21. Chen R-H, Ebner R and Derynck R (1993) Inactivation of type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260 1335-1338
22. Chen R-H, Miettinen PJ, Maruoka EM, Choy L and Derynck R (1995a) A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377 548-552
23. Chen R-H, Moses HL, Maruoka EM, Derynck R and Kawabata M (1995b) Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-β receptors. Journal of Biological Chemistry 270 12235-12241
24. Childs SR, Wrana JL, Arora K et al (1993) Identification of a Drosophila activin receptor. Proceedings of the National Academy of Sciences of the USA 90 9475-9479
25. Daksis JI, Lu RY, Facchini LM and Marhin WW (1994) Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9 3635-3645
26. Datto MB, Li Y, Panus JF et al (1995a) Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanisms. Proceedings of the National Academy of Sciences of the USA 92 5545-5549
27. Datto MB, Yu Y and Wang X-F (1995b) Functional analysis of the transforming growth factor β responsive elements in WAF1/Cip1/p21 promoter. Journal of Biological Chemistry 270 28623-28628
28. di Clemente N, Wilson C, Faure E et al (1994) Cloning expression and alternative splicing of the receptor for anti-Müllerian hormone. Molecular Endocrinology 8 1006-1020
29. Ebner R, Chen R-H, Shum L et al (1993) Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260 1344-1348
30. Estevez M, Attisano L, Wrana JL et al (1993) The daf-4 gene encodes a bone morphogenetic protein receptor controlling C elegans larva development. Nature 365 644-649
31. Ewen ME, Sluss HK, Whitehouse LL and Livingston DM (1993) TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74 1009-1020
32. Feng X-H, Filvaroff EH, Derynck R (1995) Transforming growth factor-β (TGF-β)-induced down regulation of cyclin A expression requires a functional TGF-β receptor complex. Journal of Biological Chemistry 270 24237-24245
33. Franzén P, ten Dijke P, Ichijo H et al (1993) Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75 681-692
34. Fynan TM and Reiss M (1993) Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Critical Reviews in Oncogenesis 4 493-540
35. Garrigue-Antar L, Muñoz-Antonia T, Antonia SJ et al (1995) Missense mutations in the transforming growth factor β type II receptor in human head and neck squamous cell carcinomas. Cancer Research 55 3982-3987
36. Geiser AG, Letterio JJ, Kulkarni AB et al (1993) Tranforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proceedings of the National Academy of Sciences of the USA 90 9944-9948
37. Georgi LL, Albert PS and Riddle DL (1990) daf-1 a C elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell 61 635-645
38. Gibbs JB, Oliff A and Kohl NE (1994) Farnesyltransferase inhibitors: ras research yields a potential cancer therapeutic. Cell 77 175-178
39. Glick AB, Lee MM, Darwiche N et al (1994) Targeted deletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes and Development 8 2429-2440
40. Gougos A and Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. Journal of Biological Chemistry 265 8361-8364
41. Graff JM, Thies RS, Song JJ, Celeste AJ and Melton DA (1994) Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell 79 169-179
42. Grieder NC, Nellen D, Burke R, Basler K and Affolter M (1995) shnurri is required for Drosophila Dpp signaling and encodes a zinc finger protein similar to the mammalian transcription factor PRDII-BF1. Cell 81 791-800
43. Hannon GJ and Beach D (1994) p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371 257-261
44. Harland RM (1994) The transforming growth factor β family and induction of vertebrate mesoderm: bone morphogenetic proteins are ventral inducers. Proceedings of the National Academy of Sciences of the USA 91 10243-10246
45. Henis YI, Moustakas A, Lin HY and Lodish HF (1994) The type II and III transforming growth factor-β receptors form homo-oligomers. Journal of Cell Biology 126 139-154
46. Hinds P and Weinberg RA (1994) Tumor suppressor genes. Current Opinion in Genetics and Development 4 135-141
47. Hötten G, Neidhardt H, Schneider C and Pohl J (1995) Cloning of a new member of the TGF-β family: a putative new activin βC chain. Biochemical and Biophysical Research Communications 206 608-613
48. Hunter T and Pines J (1994) Cylins and cancer II: cyclin D and CDK inhibitiors come of age. Cell 79 573-582
49. Imbeaud S, Faure E, Lamarre I et al (1995) Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor. Nature Genetics 11 382-388
50. Inagaki M, Moustakas A, Lin HY, Lodish HF and Carr BI (1993) Growth inhibition by transforming growth factor-β (TGF-β) is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II. Proceedings of the National Academy of Sciences of the USA 90 5359-5363
51. Inagaki Y, Truter S and Ramirez F (1994) TGF-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. Journal of Biological Chemistry 269 14828-14834
52. Jayaraman T and Marks AR (1993) Rapamycin-FKBP12 blocks proliferation induces differentiation and inhibits cdc2 kinase activity in a myogenic cell line. Journal of Biological Chemistry 268 25385-25388
53. Kadin ME, Cavaille-Coll MW, Gertz R et al (1994) Loss of receptors to transforming growth factor β in human T-cell malignancies. Proceedings of the National Academy of Sciences of the USA 91 6002-6006
54. Kawabata M, Chytil A and Moses HL (1995a) Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-β receptor. Journal of Biological Chemistry 270 5625-5630
55. Kawabata M, Imamura T, Miyazono K, Engel ME and Moses HL (1995b) Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. Journal of Biological Chemistry 270 29628-29631
56. Knebelmann B, Boussin L, Guerrier D et al (1991) Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome. Proceedings of the National Academy of Sciences of the USA 88 3767-3771
57. Koenig BB, Cook JS, Wolsing DH et al (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH3T3 cells. Molecular and Cellular Biology 14 5961-5974
58. 1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260 536-539
59. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM and Massagué J (1990) Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62 175-185
60. Laiho M, Weis FMB, Boyd FT, Ignotz RA and Massagué J (1991) Responsiveness to transforming growth factor-β restored by complementation between cells defective in TGF-β receptors I and II. Journal of Biological Chemistry 266 9108-9112
61. Laiho M, Weis FMB and Massagué J (1990) Concomitant loss of transforming growth factor-β receptor types I and II in cell mutants resistant to TGF-β. Journal of Biological Chemistry 265 18518-18524
62. Letsou A, Arora K, Wrana J et al (1995) Drosophila dpp signaling is mediated by the punt gene product: a dual ligand binding type II receptor of the TGF-β receptor family. Cell 80 899-908
63. Ink4B through an Sp1 consensus site. Journal of Biological Chemistry 270 26750-26753
64. Lin HY, Wang X-F, Ng-Eaton E, Weinberg R and Lodish H (1992) Expression cloning of the TGF-β type II receptor a functional transmembrane serine/threonine kinase. Cell 68 775-785
65. Liu F, Ventura F, Doody J and Massagué J (1995) Human type II receptor for bone morphogenetic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Molecular and Cellular Biology 15 3479-3486
66. López-Casillas F, Cheifetz S, Doody J et al (1991) Structure and expression of the membrane proteoglycan betaglycan a component of the TGF-β receptor system. Cell 67 785-795
67. López-Casillas F, Wrana JL and Massagué J (1993) Betaglycan presents ligand to the TGF-β signaling receptor. Cell 73 1435-1444
68. López-Casillas F, Payne HM, Andres JL and Massagué J (1994) Betaglycan is a dual regulator of TGF-β access to signalling receptors. Journal of Cell Biology 124 557-568
69. McAllister KA, Grogg KM, Johnson DW et al (1994) Endoglin a TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics 8 345-351
70. Maeno M, Ong RC, Suzuki A, Ueno N and Kung H-F (1994) A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm. Proceedings of the National Academy of Sciences of the USA 91 10260-10264
71. Markowitz S, Wang J, Myeroff L et al (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268 1336-1338
72. Massagué J (1990) The transforming growth factor-β family. Annual Review of Cell Biology 6 597-641
73. Massagué J (1996) TGFβ signaling: receptors, transducers and Mad proteins. Cell 85 947-950
74. Mathew S, Murty VVV, Cheifetz S et al (1994) Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics 20 114-115
75. Mathews LS and Vale WW (1991) Expression cloning of an activin receptor, a predicted transmembrane kinase. Cell 65 973-982
76. Mathews LS and Vale WW (1993) Characterization of type II activin receptors: binding, processing and phosphorylation. Journal of Biological Chemistry 268 19013-19018
77. Mathews LS, Vale WW and Kintner CR (1992) Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science 255 1702-1705
78. Matzuk MM, Kumar TR and Bradley A (1995) Different phenotypes for mice deficient in either activins or the activin type II receptor. Nature 374 356-359
79. Mienttinen PJ, Ebner R, Lopez AR and Derynck R (1994) TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. Journal of Cell Biology 127 2021-2036
80. Miyazono K, Ichijo H and Heldin C-H (1993) Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors 8 11-22
81. Morgan DO (1995) Principles of CDK regulation. Nature 374 131-134
82. Moses HL, Yang EY and Pietenpol JA (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63 245-247
83. Murphy-Ullrich JE Schultz-Cherry S and Höök M (1992) Transforming growth factor-β complexes with thrombospondin. Molecular Biology of the Cell 3 181-188
84. Nakamura T, Takio K, Eto Y et al (1990) Activin-binding protein from rat ovary is follistatin. Science 247 836-838
85. Nellen D, Affolter M and Basler K (1994) Receptor ser/thr kinases implicated in the control of Drosophila body pattern by decapentaplegic. Cell 78 225-237
86. Nohno T, Ishikawa T, Saito T et al (1995) Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. Journal of Biological Chemistry 270 22522-22526
87. O'Connor-McCourt MD and Wakefield LM (1987) Latent transforming growth factor-β in serum: a specific complex with α2-macroglobulin. Journal of Biological Chemistry 262 14090-14099
88. Okadome T, Yamashita H, Franzén P et al (1994) Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. Journal of Biological Chemistry 269 30753-30756
89. Okamoto A, Hussain SP, Hagiwara K et al (1995) Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Research 55 1448-1451
90. INK4B/MTS2 in human leukemias and lymphomas. Cancer Research 55 1436-1440
91. Park K, Kin S-J, Bang YJ et al (1994) Genetic changes in the transforming growth factor β type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proceedings of the National Academy of Sciences of the USA 91 8772-8776
92. Penton A, Chen Y, Staehling-Hampton K et al (1994) Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell 78 239-250
93. Reynisdóttir I, Polyak K, Iavarone A and Massagué J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arest in response to TGF-β. Genes and Development 9 1831-1845
94. Roberts AB and Sporn MB (1990) The transforming growth factor-betas, In: Sporn MB and Roberts AB (eds). Peptide growth factors and their receptors, pp 419-472, Springer-Verlag, Heidelberg
95. Rosenzweig BL, Imamura T, Okadome T et al (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proceedings of the National Academy of Sciences of the USA 92 7632-7636
96. Ruberte E, Marty T, Nellen D, Affolter M and Basler K (1995) An absolute requirement for both the type II and type I receptors, punt and thick veins, for dpp signaling in vivo. Cell 80 889-897
97. Schreiber S (1992) Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 70 385-368
98. Segarini PR and Seyedin SM (1988) The high molecular weight receptor to transforming growth factor-β contains glycosaminoglycan chains. Journal of Biological Chemistry 263 8366-8370
99. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH and Gelbart WM (1995) Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139 1347-1358
100. 1 phase progression: cycling on cue. Cell 79 551-555
101. 1 cyclin-dependent kinases. Genes and Development 9 1149-1163
102. Shull MM, Ormsby I, Kier AB et al (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359 693-699
103. Sieweke MH, Thompson NL, Sporn MB and Bissell MJ (1990) Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-β. Science 248 1656-1660
104. 1 cyclin-cdk complexes. EMBO Journal 14 4814-4826
105. Sun PD and Davies D (1995) The cystine-knot growth factor superfamily. Annual Review of Biophysics and Biomolecular Structure 24 269-291
106. ten Dijke P, Ichijo H, Franzén P et al (1993) Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8 2879-2887
107. ten Dijke P, Yamashita H, Ichijo H et al (1994a) Characterization of type I receptors for transforming growth factor-β and activin. Science 264 101-104
108. ten Dijke P, Yamashita H, Sampath TK et al (1994b) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. Journal of Biological Chemistry 269 16985-16988
109. Ullrich A and Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61 203-212
110. Vale W, Hsueh A, Rivier C and Yu J (1990) The inhibin/activin family of hormones and growth factors, In: Sporn MB and Roberts AB (eds). Peptide growth factors and their receptors, pp 211-248.95, Springer-Verlag, Heidelberg
111. Ventura F, Doody J, Liu F, Wrana JL and Massagué J (1994) Reconstitution and transphos-phorylation of TGF-β receptor complexes. EMBO Journal 13 5581-5589
112. Ventura F, Liu F, Doody J and Massagué J (1996) Transforming growth factor-β receptor type I interacts with farnesyl transferase-α in mammalian cells. journal of Biological Chemistry 271 13931-13934
113. Vivien D, Attisano L, Ventura F, Wrana JL and Massagué J (1995) Signaling activity of homologous and heterologous TGF-β receptor kinase complexes. Journal of Biological Chemistry 270 7134-7141
114. Wahl SM (1992) Transforming growth factor-β (TGF-β) in inflammation: a cause and a cure. Journal of Clinical Immunology 12 61-74
115. Wang T, Donahoe PK and Zervos AS (1994) Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 265 674-676
116. Wang T, Danielson PD, Li B, Shah PC, Kim SD and Donohoe PK (1996) The p21RAS farnesyltransferase α subunit in TGF-β and activin signaling. Science 271 1120-1122
117. Wang X-F, Lin HY, Ng-Eaton E et al (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell 67 797-805
118. Weis-Garcia F and Massagué J (1996) Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO Journal 15 276-289
119. Wieser R, Attisano L, Wrana JL and Massagué J (1993) Signalling activity of TGF-β type II receptors lacking specific domains in the cytoplasmic region. Molecular and Cellular Biology 13 7239-7247
120. Wieser R, Wrana JL and Massagué J (1995) GS domain mutations that constitutively activate TßR-I, the downstream signaling component in the TGF-β receptor complex. EMBO Journal 14 2199-2208
121. Williams LT (1989) Signal transduction by the platelet-derived growth factor receptor. Science 243 1564-1570
122. INK4A-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in human melanoma. Science 269 1281-1284
123. Wrana JL, Attisano L, Carcamo J et al (1992) TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71 1003-1014
124. Wrana JL, Attisano L, Wieser R, Ventura F and Massagué J (1994a) Mechanism of activation of the TGF-β receptor. Nature 370 341-347
125. Wrana JL, Tran H, Attisano L et al (1994b) Two distinct transmembrane serine/threonine kinases from Drosophila form an activin receptor complex. Molecular and Cellular Biology 14 944-950
126. Xie T, Finelli AL and Padgett RW (1994) The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-β superfamily. Science 263 1756-1759
127. Yamaguchi Y, Mann DM and Ruoslahti E (1990) Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346 281-283
128. Yamashita H, ten Dijke P, Franzén P, Miyazono K and Heldin C-H (1994) Formation of heterooligomeric complexes of type I and type II receptors for transforming growth factor-β. Journal of Biological Chemistry 269 20172-20178
129. Yamashita H, ten Dijke P, Huylebroeck D et al (1995) Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. Journal of Cell Biology 130 217-226
130. Zentella A and Massagué J (1992) TGF-β induces myoblast differentiation in the presence of mitogens. Proceedings of the National Academy of Sciences of the USA 89 5176-5180